Sirna, conjugate which contain sirna, pharmaceutical composition and uses thereof

TW202631158APending Publication Date: 2026-08-01JIANGSU HANSOH PHARMA CO LTD +2

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114135016
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-03-12
Filing Date: 2025-09-11
Publication Date: 2026-08-01

Application Information

Patent Timeline

12 Mar 2025

Priority

11 Sep 2025

Application

TW114135016

01 Aug 2026

Publication

TW202631158A

IPC: A61K31/713; A61K47/54; A61P13/12; A61P21/00; A61P27/02; C12N15/113

Inventors: 管小陽; 丁昱

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to siRNA, e.g., double stranded ribonucleic acid (dsRNA), that interfere with target gene expression or inhibit its expression. The invention also relates to a conjugate or a pharmaceutical composition containing the siRNA. And the use of the siRNA, the conjugate and the pharmaceutical composition thereof in preparing a drug used for treating and / or preventing the disease or disorder.

Need to check novelty before this filing date? Find Prior Art